Form 4: Intellicheck CEO Bryan Lewis Acquires Stock Options
SEC Form 4 Filing
Intellicheck's CEO, Bryan Lewis, acquired stock options with varying exercise prices and vesting schedules.
Summary
- Bryan Lewis, CEO/President and Director of Intellicheck, Inc., acquired stock options on March 15, 2024.
- He acquired 66,500 stock options with an exercise price of $1.81, 33,250 stock options with an exercise price of $1.99, and 33,250 stock options with an exercise price of $2.17.
- The options vest over three years, with one-third vesting on the first anniversary of the grant date and the remaining two-thirds vesting quarterly over the following two years.
- The options expire on March 15, 2031.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock option grants to the CEO. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider transactions.
Positives
- The acquisition of stock options by the CEO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the CEO.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the compensation structure and equity ownership of key executives.
Comparison to Industry Standards
- Stock option grants are a common form of executive compensation in the technology industry, used to incentivize performance and align management interests with shareholder value.
- Vesting schedules, like the three-year schedule described, are standard practice to ensure long-term commitment.
- Companies like Block, Inc. and Palantir Technologies also use stock options as part of their executive compensation packages.
Stakeholder Impact
- The stock option grant could potentially incentivize the CEO to improve company performance, benefiting shareholders.
- Employees may view the CEO's stock option grant as a positive sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of the stock option grant |
| 03/15/2025 | First vesting date for one-third of the options |
| 03/15/2031 | Expiration date of the stock options |
| 03/19/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.